Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Customer Focus - Physician/Prescribing

Sponsored by

Finalist

Save Sight Years (SSY) - A medical education programme developed by glaucoma specialists for glaucoma specialists

Allergan in association with Darwin Healthcare Communications


Summary of work

The Save Sight Years (SSY) programme was developed with Professor Anders Heijl as part of Allergan’s commitment to support ophthalmologists in caring for their patients. 

Professor Heijl is a leading glaucoma specialist. He is chief ophthalmological adviser to the Swedish National Board of Health and Welfare, and leads the group of experts producing a systematic literature review on the diagnosis and treatment of open-angle glaucoma for the Swedish Council on Technology Assessment in Health Care. Professor Heijl has authored over 200 scientific publications.

Based on Professor Heijl’s concept of saving sight years, the objective of the SSY programme was to communicate the importance of early glaucoma treatment for patient quality of life and to encourage best practice – more frequent monitoring, regular calculation of rate of progression and tailored treatment. 

The SSY programme also aimed to highlight the patient’s perspective to physicians – the effect of glaucoma on their daily life and how reduced vision affects their activities – while encouraging changes to clinical practice. SSY brings together video patient case studies, lectures and workshops for local delivery by leading glaucoma specialists. 

In 2011, more than 7000 general ophthalmologists across Europe, Middle East, Africa and Asia Pacific were trained using the SSY programme.

 

 

Executive summary as submitted


COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...

Infographics